These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26319144)

  • 1. Biologic therapy for refractory scleritis: a new treatment perspective.
    de Fidelix TS; Vieira LA; de Freitas D; Trevisani VF
    Int Ophthalmol; 2015 Dec; 35(6):903-12. PubMed ID: 26319144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
    Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.
    Tragiannidis A; Kyriakidis I; Zündorf I; Groll AH
    Mycoses; 2017 Apr; 60(4):222-229. PubMed ID: 27766695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor necrosis factor-α therapy in uveitis.
    Cordero-Coma M; Sobrin L
    Surv Ophthalmol; 2015; 60(6):575-89. PubMed ID: 26164735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.
    Ragam A; Kolomeyer AM; Fang C; Xu Y; Chu DS
    Ocul Immunol Inflamm; 2014 Dec; 22(6):469-77. PubMed ID: 24354512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents).
    Baddley JW; Cantini F; Goletti D; Gómez-Reino JJ; Mylonakis E; San-Juan R; Fernández-Ruiz M; Torre-Cisneros J
    Clin Microbiol Infect; 2018 Jun; 24 Suppl 2():S10-S20. PubMed ID: 29459143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.
    Yun H; Xie F; Delzell E; Levitan EB; Chen L; Lewis JD; Saag KG; Beukelman T; Winthrop KL; Baddley JW; Curtis JR
    Arthritis Rheumatol; 2016 Jan; 68(1):56-66. PubMed ID: 26315675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful infliximab treatment of posterior scleritis in a 13-year-old child refractory to other immunosuppressive therapy.
    Weiss K; Rieger R; Keitzer R; Pleyer U
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1735-7. PubMed ID: 17674021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
    Gibellini L; De Biasi S; Bianchini E; Bartolomeo R; Fabiano A; Manfredini M; Ferrari F; Albertini G; Trenti T; Nasi M; Pinti M; Iannone A; Salvarani C; Cossarizza A; Pellacani G
    PLoS One; 2016; 11(12):e0167757. PubMed ID: 27936119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96).
    Onal S; Tugal-Tutkun I
    Ophthalmology; 2014 Oct; 121(10):e57-8. PubMed ID: 25064722
    [No Abstract]   [Full Text] [Related]  

  • 14. Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases.
    Lopetuso LR; Cuomo C; Mignini I; Gasbarrini A; Papa A
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review on biological therapies in juvenile idiopathic inflammatory myopathies: an evidence gap in precision medicine.
    Marrani E; Abu-Rumeileh S; Mastrolia MV; Maccora I; Pagnini I; Simonini G
    Clin Exp Rheumatol; 2022 Feb; 40(2):457-470. PubMed ID: 34905479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current status of biological treatment for uveitis.
    Gaggiano C; Sota J; Gentileschi S; Caggiano V; Grosso S; Tosi GM; Frediani B; Cantarini L; Fabiani C
    Expert Rev Clin Immunol; 2020 Aug; 16(8):787-811. PubMed ID: 32700605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certolizumab pegol for the management of Crohn's disease in adults.
    Rivkin A
    Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
    Theodossiadis PG; Markomichelakis NN; Sfikakis PP
    Retina; 2007; 27(4):399-413. PubMed ID: 17420690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    Rheumatology (Oxford); 2020 Oct; 59(10):2711-2724. PubMed ID: 32533192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF inhibitors for psoriasis.
    Chima M; Lebwohl M
    Semin Cutan Med Surg; 2018 Sep; 37(3):134-142. PubMed ID: 30215629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.